An Affiliate of Genesis Bio-Pharmaceuticals Inc, USA





Home       |       Company/Mgt. Profile       |        Specialty Products       |        Medical Devices        |         Orders/Quotation       |        Contact Us





                   

 


(Streptokinase) 

 

Indications and Usage

Acute Evolving Transmural Myocardial Infarction: Streptase® is indicated for use in the management of acute myocardial infarction (AMI) in adults, for the lysis of intracoronary thrombi, the improvement of ventricular function, and the reduction of mortality associated with AMI, when administered by either the intravenous or the intracoronary route, as well as for the reduction of infarct size and congestive heart failure associated with AMI when administered by the intravenous route.

Pulmonary Embolism: Streptase® is indicated for the lysis of objectively diagnosed (angiography or lung scan) pulmonary emboli, involving obstruction of blood flow to a lobe or multiple segments, with or without unstable hemodynamics.

Deep vein Thrombosis: Streptase® is indicated for the lysis of objectively diagnosed (preferably ascending venography), acute, extensive thrombi of the deep veins such as those involving the popliteal and more proximal vessels.

Arterial Thrombosis or Embolism: Streptase® is indicated for the lysis of acute arterial thrombi and emboli. Streptokinase is not indicated for arterial emboli originating from the left side of the heart due to the risk of new embolic phenomena such as cerebral embolism.

Occlusion of Arteriovenous Cannulae: Streptase® is indicated as an alternative to surgical revision for clearing totally or partially occluded arteriovenous cannulae when acceptable flow cannot be achieved.

Contraindications

Because thrombolytic therapy increase the risk of bleeding, Streptase® is contraindicated in the following situations:

  • active internal bleeding
  • recent (within 2 months) cerebrovascular accident, intracranial or intraspinal surgery
  • intracranial neoplasm
  • severe uncontrolled hypertension Streptase

Streptokinase should not be administered to patients having experienced severe allergic reaction to the product.

As with other fibrinolytics, use with caution in patients with conditions that increase the risk of hemorrhage, including use with antiplatelet agents, which may cause bleeding complications. Severe internal bleeding, allergic reactions, and rarely anaphylactoid reactions have been associated with Streptokinase therapy.

Full prescribing information for Streptase®
www.streptase.com




 
Please Note that no information in this site is provided with the intention of or should be viewed as giving medical advice or instruction on the correct use of distributed products/devices. GenAsia Biotech offers the information on this website for general educational and informational only. Some of the products mentioned on this site might not registered in your country.




© Copyright 2003 GenAsia Biotech. All Rights Reserved
GenAsia Biotech L.L. Corp.
UG 41 CITYLAND PIONEER
128 Pioneer St. Mandaluyong City 1550
Philippines
Hotline : +63 917-820-2020